Cargando…

Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease

BACKGROUND: The predictive role of retinol-binding protein 4 (RBP4) in the adverse prognosis of patients with stable coronary artery disease (CAD) has not been well-defined. We thus conducted this cohort study to investigate the association between circulating RBP4 level and major adverse cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Ke, Yan, Xin, Xu, Cheng, Fang, Yijia, Ma, Moshuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968078/ https://www.ncbi.nlm.nih.gov/pubmed/35369314 http://dx.doi.org/10.3389/fcvm.2022.829347

Ejemplares similares

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Relation Between Plasma Proteomics Analysis and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Dregoesc, Mihaela Ioana, et al.
Publicado: (2022)

Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial
por: Shi, Haiming, et al.
Publicado: (2022)

Risk factors for major adverse cardiovascular events after coronary artery bypass grafting using radial artery grafts
por: Xia, Tianyu, et al.
Publicado: (2023)

Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
por: Yang, Sheng-Hua, et al.
Publicado: (2017)

Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease
por: Meeuwsen, John A. L., et al.
Publicado: (2017)

Editorial: Advances in predicting future adverse coronary events: the role of cardiovascular imaging and coronary physiology indices
por: Seitun, Sara, et al.
Publicado: (2023)

Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia
por: Cai, Zhongxing, et al.
Publicado: (2021)

Acute Lower Respiratory Tract Infection Increased the Risk of Cardiovascular Events and All-Cause Mortality in Elderly Patients With Stable Coronary Artery Disease
por: Zhao, Xiaoqian, et al.
Publicado: (2021)

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Coronary Revascularization in Patients With Stable Coronary Artery Disease: The Role of Imaging
por: Neglia, Danilo, et al.
Publicado: (2021)

Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events
por: Song, Mowei, et al.
Publicado: (2023)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
por: Cheng, Lele, et al.
Publicado: (2021)

The role of cardiac computed tomography in predicting adverse coronary events
por: Emfietzoglou, Maria, et al.
Publicado: (2022)

Coronary artery calcium score on standard of care oncologic CT scans for the prediction of adverse cardiovascular events in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Koutroumpakis, Efstratios, et al.
Publicado: (2022)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy
por: Gao, Mingxin, et al.
Publicado: (2023)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2021)

Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease
por: Maguire, Patricia B., et al.
Publicado: (2020)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease
por: Gao, Jie, et al.
Publicado: (2022)

Comparison of conventional scoring systems to machine learning models for the prediction of major adverse cardiovascular events in patients undergoing coronary computed tomography angiography
por: Ghorashi, Seyyed Mojtaba, et al.
Publicado: (2022)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Traditional Cardiovascular Risk Factors and Coronary Collateral Circulation: A Meta-Analysis
por: Pei, Junyu, et al.
Publicado: (2021)

Risk prediction model for major adverse cardiovascular events (MACE) during hospitalization in patients with coronary heart disease based on myocardial energy metabolic substrate
por: Na, Li, et al.
Publicado: (2023)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis
por: Zhou, Yimo, et al.
Publicado: (2021)

Association of High Serum Adiponectin Level With Adverse Cardiovascular Outcomes and Progression of Coronary Artery Calcification in Patients With Pre-dialysis Chronic Kidney Disease
por: Suh, Sang Heon, et al.
Publicado: (2022)

Directly Measured vs. Calculated Low-Density Lipoprotein Cholesterol Does Not Identify Additional Individuals With Coronary Artery Disease and Diabetes at Higher Risk of Adverse Events: Insight From a Large Percutaneous Coronary Intervention Cohort in Asia
por: Shi, Boqun, et al.
Publicado: (2022)

Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans
por: Ferrannini, Ele, et al.
Publicado: (2022)

A Left Ventricular Mechanical Dyssynchrony-Based Nomogram for Predicting Major Adverse Cardiac Events Risk in Patients With Ischemia and No Obstructive Coronary Artery Disease
por: Zhang, Han, et al.
Publicado: (2022)

Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors
por: Ma, Yue, et al.
Publicado: (2022)

Machine learning models of clinically relevant biomarkers for the prediction of stable obstructive coronary artery disease
por: Kim, Juntae, et al.
Publicado: (2022)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p69ffqvc8gc3125vb8q2k0se83